Information was collected on weight, health outcomes, vaccination history and vaccine-preventable disease serology. After parental consent, DBSs were collected from participants to assess immunity to vaccine-preventable diseases and processed at the University of California, Los Angeles (UCLA)—DRC laboratory at the National Laboratory for Biomedical Research in Kinshasa. All survey data were transferred from paper questionnaires to an electronic format using the Census and Survey Processing System (U.S. Census Bureau, ICF Macro). Data were double entered and verified by comparison of both datasets.
At the time of interview, if mothers possessed a health care worker-provided vaccination card indicating the date the child was vaccinated, this was considered a “dated card” report. Since “dated card” reports are considered most reliable, we utilized only this type of report when categorizing a child as vaccinated, whether the vaccination was against tetanus or measles. Children classified as “unvaccinated” in this study were those reported as such in the 2013–2014 DHS. Tetanus vaccination status was obtained via dated vaccination card and limited to children receiving the complete 3-dose vaccination series (all other children were removed from analyses). Due to concern of live versus killed vaccines resulting in nonspecific effects on vaccinees,18 (link) we examined whether the DTwPHibHepB versus measles vaccine was given last within the sample of participating children. Of the 649 children who received both DTwPHibHepB and measles vaccines, 5 (0.1%) children received DTwPHibHepB after the measles vaccine (indicating an incorrect vaccination schedule), 22 (3.3%) children received both vaccines within the same month and 622 (96%) received the measles vaccine after DTwPHibHepB. We did not examine other vaccines a child may have received.